Article Information
History
- September 23, 2024.
Article Versions
- Version 1 (July 24, 2024 - 14:43).
- You are currently viewing Version 2 of this article (September 23, 2024 - 12:06).
- View Version 3, the most recent version of this article.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Author Information
- Julio F. Mateus Nino1,*,
- Julia Wynn2,
- Jenny Wiggins-Smith4,
- J. Brett Bryant5,
- J. Kris Citty6,
- J. Kyle Citty6,
- Samir Ahuja7 and
- Roger Newman2
- 1Atrium Health, Charlotte, NC, US
- 2BillionToOne Inc., Menlo Park, CA, US
- 3Medical University of South Carolina, Charleston, SC, US
- 4Shannon Health, San Angelo, TX, US
- 5Unity Health Searcy, Searcy, AR, USA
- 6Wellstar Health System, Marietta, GA, US
- 7University Hospital, Mentor, OH, US
- ↵*Corresponding Author:
Julio F. Mateus Nino, MD 200 Medical Park Dr NE Ste 250, Concord, NC 28025, United States Julio.MateusNino{at}atriumhealth.org
Posted September 23, 2024.
Clinical performance of cell free DNA for fetal RhD detection in RhD-negative pregnant individuals in the US
